EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Balance of MFN2 and OPA1 in Mitochondrial Dynamics, Cellular Homeostasis, and Disease

Paola Zanfardino iD, Alessandro Amati iD, Mirko Perrone iD, Vittoria Petruzzella iD

Biomolecules · 18.03.2025 · 15 (3) · 433

DOI: 10.3390/biom15030433 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 18.03.2025. Verfasst von Paola Zanfardino und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Piazza Giulio Cesare, 70124 Bari, Italy. Hauptthemen laut MEDLINE: GTP Phosphohydrolases, Mitochondrial Dynamics, Charcot-Marie-Tooth Disease, Mitochondrial Proteins. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 231 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Patients Associations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dynamics, governed by fusion and fission, are crucial for maintaining cellular homeostasis, energy production, and stress adaptation. MFN2 and OPA1, key regulators of mitochondrial fusion, play essential roles beyond their structural functions, influencing bioenergetics, intracellular signaling, and quality control mechanisms such as mitophagy. Disruptions in these processes, often caused by MFN2 or OPA1 mutations, are linked to neurodegenerative diseases like Charcot-Marie-Tooth disease type 2A (CMT2A) and autosomal dominant optic atrophy (ADOA). This review explores the molecular mechanisms underlying mitochondrial fusion, the impact of MFN2 and OPA1 dysfunction on oxidative phosphorylation and autophagy, and their role in disease progression. Additionally, we discuss the divergent cellular responses to MFN2 and OPA1 mutations, particularly in terms of proliferation, senescence, and metabolic signaling. Finally, we highlight emerging therapeutic strategies to restore mitochondrial integrity, including mTOR modulation and autophagy-targeted approaches, with potential implications for neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GTP PhosphohydrolasesMitochondrial DynamicsCharcot-Marie-Tooth DiseaseMitochondrial ProteinsHumansHomeostasisAnimalsMitochondriaAutophagyOptic Atrophy, Autosomal DominantMutation

Stichwörter der Autor:innen

autophagymTOR signalingmitochondriamitochondrial dynamicsmitophagyneurodegenerative diseasesoxidative phosphorylationproliferationsenescence

Substanzen

GTP PhosphohydrolasesOPA1 protein, humanMFN2 protein, humanMitochondrial Proteins

Autor:innen und Institutionen

  • Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Piazza Giulio Cesare, 70124 Bari, Italy.

ORCID-Profile: Paola Zanfardino, Alessandro Amati, Mirko Perrone, Vittoria Petruzzella

Förderung

  • Patients Associations

Zitieren

APA

Zanfardino, P., Amati, A., Perrone, M., & Petruzzella, V. (2025). The Balance of MFN2 and OPA1 in Mitochondrial Dynamics, Cellular Homeostasis, and Disease. Biomolecules, 15(3), 433. https://doi.org/10.3390/biom15030433

Vancouver

Zanfardino P, Amati A, Perrone M, Petruzzella V. The Balance of MFN2 and OPA1 in Mitochondrial Dynamics, Cellular Homeostasis, and Disease. Biomolecules. 2025;15(3):433. doi:10.3390/biom15030433

BibTeX
@article{Zanfardino2025,
  author = {Zanfardino, Paola and Amati, Alessandro and Perrone, Mirko and Petruzzella, Vittoria},
  title = {The Balance of MFN2 and OPA1 in Mitochondrial Dynamics, Cellular Homeostasis, and Disease},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {3},
  pages = {433},
  doi = {10.3390/biom15030433}
}
Kostenlos starten →